Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

1.14.19.20: DELTA7-sterol 5(6)-desaturase

This is an abbreviated version!
For detailed information about DELTA7-sterol 5(6)-desaturase, go to the full flat file.

Word Map on EC 1.14.19.20

Reaction

a DELTA7-sterol
+ 2 ferrocytochrome b5 +
O2
+ 2 H+ =
a DELTA5,7-sterol
+ 2 ferricytochrome b5 + 2 H2O

Synonyms

5-DES, 5alpha-cholest-7-en-3beta-ol:oxygen DELTA5-oxidoreductase, C-5 sterol desaturase, C-5(6) sterol desaturase, Delta-7-sterol 5-desaturase, DELTA7-sterol 5-desaturase, DELTA7-sterol C56-desaturase, DELTA7-sterol DELTA5-dehydrogenase, DELTA7-sterol-C-5-desaturase, DELTA7-sterol-C5 (6)-desaturase, DELTA7-sterol-C5(6)-desaturase, DELTA7-sterol-C5-desaturase, DES5A, Des5Ap, Dhcr7, DWARF7, EC 1.14.21.6, EC 1.3.3.2, ERG 3, ERG3, erg32, Erg3p, FvC5SD, Lathosterol 5-desaturase, lathosterol oxidase, oxidase, lathosterol, Sc5d, SC5DL, SCSD, STE1, sterol C5-desaturase, sterol DELTA5,6-desaturase, sterol DELTA7-reductase, Sterol-C5-desaturase

ECTree

     1 Oxidoreductases
         1.14 Acting on paired donors, with incorporation or reduction of molecular oxygen
             1.14.19 With oxidation of a pair of donors resulting in the reduction of O2 to two molecules of water
                1.14.19.20 DELTA7-sterol 5(6)-desaturase

Inhibitors

Inhibitors on EC 1.14.19.20 - DELTA7-sterol 5(6)-desaturase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(3S,20S)-20-N-(2-methylpropyl)carbamoylpregn-7-en-3beta-ol
-
specific
(3S,20S)-20-N-(2-methylpropyl)carbamoylpregn-7-en-3beta-yl acetate
-
specific for the enzyme. Prodrug, transformed into the 3beta-hydroxy derivative under in vitro conditions
(3S,20S)-20-N-butylcarbamoylpregn-7-en-3beta-ol
-
specific
(3S,20S)-20-N-butylcarbamoylpregn-7-en-3beta-yl acetate
-
specific for the enzyme. Prodrug, transformed into the 3beta-hydroxy derivative under in vitro conditions
(3S,20S)-20-N-ethylcarbamoylpregn-7-en-3beta-ol
-
-
(3S,20S)-20-N-ethylcarbamoylpregn-7-en-3beta-yl acetate
-
-
(3S,20S)-20-N-pentylcarbamoylpregn-7-en-3beta-ol
-
specific
(3S,20S)-20-N-pentylcarbamoylpregn-7-en-3beta-yl acetate
-
specific for the enzyme. Prodrug, transformed into the 3beta-hydroxy derivative under in vitro conditions
(3S,20S)-20-N-propylcarbamoylpregn-7-en-3beta-ol
-
-
(3S,20S)-20-N-propylcarbamoylpregn-7-en-3beta-yl acetate
-
-
(3S,20S)-20-N-tert-butylcarbamoylpregn-7-en-3beta-ol
-
specific
(3S,20S)-20-N-tert-butylcarbamoylpregn-7-en-3beta-yl acetate
-
specific for the enzyme. Prodrug, transformed into the 3beta-hydroxy derivative under in vitro conditions
1,10-phenanthroline
2-(4-phenethylpiperazin-1-yl)-1-(pyridine-3-yl)ethanol
-
average content of 7-dehydrocholesterol in human primary hepatocytes after 2-(4-phenethylpiperazin-1-yl)-1-(pyridine-3-yl)ethanol treatment is, 34.16 times higher than that in nontreated cells, indicating that DHCR7 is the major target (minor targets are human sterol DELTA14-reductase, sterol DELTA24-reductase, and sterol C5-desaturase). In vitro kinetic measurements show that the half-life of 2-(4-phenethylpiperazin-1-yl)-1-(pyridine-3-yl)ethanol is at least 4.3 h. 2-(4-phenethylpiperazin-1-yl)-1-(pyridine-3-yl)ethanol does not induce CYP3A4 mRNA nor enzyme activity
4,5-dihydroxy-1,3-benzene-disulfonic acid
-
trivial name tiron, 0.5 mM, 80% inhibition
alpha-(2,4-dichlorophenyl)-alpha-phenyl-5-pyrimidine methanol
-
trivial name triarimol, weak inhibition
anti-cytochrome b5 antibodies
-
0.5 mg/mg protein. 36% inhibition
-
bathophenanthroline
-
0.5 mM, 71% inhibition
cyanide
CYC (cyctochrome c)
-
-
-
dithiothreitol
-
1.0 mM, 55% inhibition
lathosterol side chain amides
-
synthesis and compound screening, influence of different sterol amides on inhibition of the enzyme, overview, lathosterol-derived amides with larger substituents, e.g. butyl, isobutyl, tert-butyl, pentyl, at the amide nitrogen are selective inhibitors of lathosterol oxidase, overview
-
menadione
-
32% residual actitivty at 0.05 mM
posaconazole
-
Salicylhydroxamic acid
-
-
salicylic hydroxamic acid
-
-
Tiron
-
21% residual activity at 1 mM
Triarimol
-
weak inhibition
additional information
-